Literature DB >> 11024422

Intraocular pressure and visual field progression in open-angle glaucoma.

M A Kass, M O Gordon.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11024422     DOI: 10.1016/s0002-9394(00)00658-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  6 in total

1.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

2.  Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.

Authors:  H Schori; J Kipnis; E Yoles; E WoldeMussie; G Ruiz; L A Wheeler; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 3.  [Neuroprotection against glaucoma remains a concept].

Authors:  N N Osborne; K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

4.  Systemic Arterial Stiffness Is Associated With Structural Progression in Early Open-Angle Glaucoma.

Authors:  Jihei Sara Lee; Hyoung Won Bae; Sungeun Park; Chan Yun Kim; Sang Yeop Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

5.  Microvascular damage assessed by optical coherence tomography angiography for glaucoma diagnosis: a systematic review of the most discriminative regions.

Authors:  Amerens Bekkers; Noor Borren; Vera Ederveen; Ella Fokkinga; Danilo Andrade De Jesus; Luisa Sánchez Brea; Stefan Klein; Theo van Walsum; João Barbosa-Breda; Ingeborg Stalmans
Journal:  Acta Ophthalmol       Date:  2020-03-16       Impact factor: 3.761

6.  TonoVet versus Tonopen in a high intraocular pressure monkey model.

Authors:  Shu Tu; Kang Li; Xiaohu Ding; Chengguo Zuo; Dongpeng Hu; Jian Ge
Journal:  Mol Vis       Date:  2019-08-03       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.